Chandrasekar Vijayasekar
Research Subjects
Chandrasekar Vijayasekar has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
G Mathew
2 shared publicationsG. Mathew
George Eliot Hospital
2 shared publicationsK. Marimuthu
George Eliot Hospital
2 shared publicationsB Lakshminarayanan
1 shared publicationD. Ghosh
Glenfield Hospital, Leicester, UK
1 shared publicationJ Worlding
1 shared publication
Latest Publications
- 12 November 2009
- Vol. 72 (3) , 289-95
Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
Chemotherapy-induced diarrhoea (CID) is well known in cancer management. The risk is greater when the primary cancer is colorectal. This article aims towards assessing the role of octreotide in CID through an extensive literature search. After searching through PUBMED, MEDLINE and the Cochrane library, only those studies which were published over the last 20 years in English and where at least the majority of the cohort were colorectal patients, were included. Two randomized trials, four non-randomized studies and two case-series publications were thus considered. It was seen in both the randomized studies, that octreotide had much better outcome as compared to loperamide in treating severe CID. Among 88 patients from the non-randomized studies with severe CID, the primary cancer was colorectal in 79 patients. 61 patients had drug-resistant CID. Within a maximum of 96 hours, octreotide reduced CID by > or = 2 grades in 91% of 88 patients and in 88.52% patients with drug-resistant CID. Octreotide is effective in treating severe CID, resistant to other modes of treatment. It is associated with a few minor adverse effects. Though expensive, octreotide could be considered as first line medication in CID of grades 3 or above. Its use in lower grades of CID would not be cost effective.
- 12 November 2009
- Vol. 72 (3) , 289-95
Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
Chemotherapy-induced diarrhoea (CID) is well known in cancer management. The risk is greater when the primary cancer is colorectal. This article aims towards assessing the role of octreotide in CID through an extensive literature search. After searching through PUBMED, MEDLINE and the Cochrane library, only those studies which were published over the last 20 years in English and where at least the majority of the cohort were colorectal patients, were included. Two randomized trials, four non-randomized studies and two case-series publications were thus considered. It was seen in both the randomized studies, that octreotide had much better outcome as compared to loperamide in treating severe CID. Among 88 patients from the non-randomized studies with severe CID, the primary cancer was colorectal in 79 patients. 61 patients had drug-resistant CID. Within a maximum of 96 hours, octreotide reduced CID by > or = 2 grades in 91% of 88 patients and in 88.52% patients with drug-resistant CID. Octreotide is effective in treating severe CID, resistant to other modes of treatment. It is associated with a few minor adverse effects. Though expensive, octreotide could be considered as first line medication in CID of grades 3 or above. Its use in lower grades of CID would not be cost effective.
- 1 October 2009
- Published by Elsevier in The Surgeon
- Vol. 7 (5) , 260-262
The World Health Organization's surgical safety checklist
- 1 October 2009
- Published by Elsevier in The Surgeon
- Vol. 7 (5) , 260-262
The World Health Organization's surgical safety checklist
- 18 November 2008
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 12 (4) , 309-313
Parastomal hernia: is prevention better than cure? Use of preperitoneal polypropylene mesh at the time of stoma formation
This is a prospective study of prophylactic mesh placement in the preperitoneal space at the time of stoma formation to prevent parastomal hernia. Patients undergoing elective permanent stoma formation and resiting of a stoma were included. Patients with peritoneal contamination were excluded. A 6×6-cm polypropylene mesh was placed in the preperitoneal space (no stitches), and a circular hole was made to let the bowel come through with ease and the stoma was constructed. At follow-up, the patients were examined standing and lying down for parastomal hernia. In the event of clinical uncertainty, a CT scan was done. A total of 42 patients (20 women, 22 men, mean age 61 years) were eligible for the study. The patients were followed up for a mean of 31 months (range 9–68 months). There were 29 end-colostomies and 8 end-ileostomies and 5 stomas resited. Four parastomal hernias were detected during the follow-up period (9.52%). One required repair due to an ill-fitting stoma bag and leakage. The other three were asymptomatic. One patient developed stomal necrosis which required a new segment of bowel to be brought out through the same opening and the underlying mesh was left undisturbed. The results of the 2-year follow-up in this study (incidence of parastomal herniation 9.5%) along with available evidence in the literature (incidence 0–8.3%), compared to the results of repair make a strong case for the use of a mesh at the time of initial surgery for the formation of any permanent stoma to prevent parastomal herniation.
- 18 November 2008
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 12 (4) , 309-313
Parastomal hernia: is prevention better than cure? Use of preperitoneal polypropylene mesh at the time of stoma formation
This is a prospective study of prophylactic mesh placement in the preperitoneal space at the time of stoma formation to prevent parastomal hernia. Patients undergoing elective permanent stoma formation and resiting of a stoma were included. Patients with peritoneal contamination were excluded. A 6×6-cm polypropylene mesh was placed in the preperitoneal space (no stitches), and a circular hole was made to let the bowel come through with ease and the stoma was constructed. At follow-up, the patients were examined standing and lying down for parastomal hernia. In the event of clinical uncertainty, a CT scan was done. A total of 42 patients (20 women, 22 men, mean age 61 years) were eligible for the study. The patients were followed up for a mean of 31 months (range 9–68 months). There were 29 end-colostomies and 8 end-ileostomies and 5 stomas resited. Four parastomal hernias were detected during the follow-up period (9.52%). One required repair due to an ill-fitting stoma bag and leakage. The other three were asymptomatic. One patient developed stomal necrosis which required a new segment of bowel to be brought out through the same opening and the underlying mesh was left undisturbed. The results of the 2-year follow-up in this study (incidence of parastomal herniation 9.5%) along with available evidence in the literature (incidence 0–8.3%), compared to the results of repair make a strong case for the use of a mesh at the time of initial surgery for the formation of any permanent stoma to prevent parastomal herniation.
- Open Access
- 5 September 2008
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 6 (1) , 96
Late recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer
Cutaneous metastasis from colorectal cancer after excision of the primary is a rare occurrence and presents as cutaneous or subcutaneous nodules or as a rash commonly on the anterior abdominal wall.
- 5 September 2008
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 6 (1) , 96
Open AccessLate recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer
Cutaneous metastasis from colorectal cancer after excision of the primary is a rare occurrence and presents as cutaneous or subcutaneous nodules or as a rash commonly on the anterior abdominal wall.
- 1 June 2007
- Vol. 62 (3) , 211-2
Delayed presentation of splenic rupture.
- 22 August 2006
- Published by Wiley in Colorectal Disease
- Vol. 8 (8) , 672-675
Prevention of parastomal hernia using preperitoneal mesh: a prospective observational study
Objective Parastomal hernia is a common complication after stoma formation. The objective of the study was to see whether placing prophylactic preperitoneal mesh could reduce the incidence of parastomal hernia.Method Patients having elective bowel surgery requiring permanent stoma were included in this study. The time required for mesh insertion, day of stoma function, and early complications were recorded. Follow up was at 6 weeks, 3‐monthly for the first year and at 6‐monthly intervals thereafter.Results Eighteen patients fulfilled the inclusion criteria and were followed up for 6–28 months (mean 16.05). The time taken for mesh placement was 12–22 min (mean 14). One patient had to have revision surgery on day 1 for stomal necrosis – the mesh was left in situ in that instance. This patient developed superficial laparotomy wound infection. During the follow up, no patients developed parastomal hernia, stomal prolapse, stenosis, retraction, fistula or obstruction.Conclusion The early results, in this group of patients, show that prophylactic polypropylene mesh insertion at the time of permanent stoma formation is encouraging and long‐term results are awaited.
- 22 August 2006
- Published by Wiley in Colorectal Disease
- Vol. 8 (8) , 672-675
Prevention of parastomal hernia using preperitoneal mesh: a prospective observational study
Objective Parastomal hernia is a common complication after stoma formation. The objective of the study was to see whether placing prophylactic preperitoneal mesh could reduce the incidence of parastomal hernia.Method Patients having elective bowel surgery requiring permanent stoma were included in this study. The time required for mesh insertion, day of stoma function, and early complications were recorded. Follow up was at 6 weeks, 3‐monthly for the first year and at 6‐monthly intervals thereafter.Results Eighteen patients fulfilled the inclusion criteria and were followed up for 6–28 months (mean 16.05). The time taken for mesh placement was 12–22 min (mean 14). One patient had to have revision surgery on day 1 for stomal necrosis – the mesh was left in situ in that instance. This patient developed superficial laparotomy wound infection. During the follow up, no patients developed parastomal hernia, stomal prolapse, stenosis, retraction, fistula or obstruction.Conclusion The early results, in this group of patients, show that prophylactic polypropylene mesh insertion at the time of permanent stoma formation is encouraging and long‐term results are awaited.